|
| Product | Alternate Name | Type | Strength | Quantity | Price (USD) | Buy Now | |
 |
Spiriva HandiHaler |
tiotropium bromide inhala... |
Brand |
18mcg |
30CAP |
$120.00 |
|
|
Spiriva HandiHaler |
tiotropium bromide inhala... |
Brand |
18mcg |
60CAP |
$190.00 |
|
|
Spiriva HandiHaler |
tiotropium bromide inhala... |
Brand |
18mcg |
90CAP |
$264.00 |
|
|
|
 Save. Save. Save. On Spiriva Handihaler and more!
Express-medicine.com provides customers like you access to popular top-quality pharmaceuticals at truly competitive prices. Saving you up to 80% on hundreds of medications from our Express Medicine pharmacy!
No Surprises - all your medications will come from licensed pharmacies. Your satisfaction is guaranteed. All our brand & generic products are FDA approved.
-
2010-02-06 01:37:00
Sources: buy cheap Lioresal For those of you who take respiratory medications and take them regularly think about how you take them. Do you know if you are doing it right? Being a respiratory therapist I've realized that some people still do not know how to take their medications. I have had to rete ...
-
2010-01-25 01:03:00
Recalls and Safety Alerts: Energy Levels in External Biphasic Defibrillators FDA is looking into the safety and effectiveness of biphasic defibrillators used for cardioversion and defibrillation in order to understand the conditions that affect their performance. Over the past three years, FDA has r ...
-
2010-01-20 04:45:00
Earlier in 2008 various studies thought that intake of Spiriva might cause unwanted effects for heart disease patients.But latest announcements say that it is not true.With this recent announcement, COPD patients felt relieved Spiriva Handihaler is a capsule with inhaler which needs to be taken on a ...
-
2010-01-18 04:42:00
Spiriva (tiotropium bromide) is an inhaled medication used to prevent exacerbations (”attacks”) caused by COPD, or chronic obstructive pulmonary disease. It’s taken once per day. There were concerns a while ago about a possible connection between using Spiriva and experiencing a higher risk of strok ...
-
2010-01-16 09:32:00
The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD) , do not support an increased risk of stroke, heart attack, or death in patients using the medicine. CO ...
-
2010-01-15 16:30:00
This COPD Medication Had Previously Been Possibly Linked To Stroke, Heart Attack, And Death (Posted by Tom Lamb at DrugInjuryWatch.com ) On January 14, 2010 the FDA issued a news release, "FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler -- Current data do not support increas ...
-
2010-01-15 11:43:00
The Food and Drug Administration wrapped up a safety review of the lung drug Spiriva HandiHaler, saying the product wasn’t associated with an increased risk of stroke or other cardiovascular problems. Spiriva is approved to treat chronic obstructive pulmonary disease, which includes chronic bronchit ...
-
2010-01-15 11:36:00
From Associated Press (January 14, 2010) WASHINGTON--Federal health regulators said Thursday that recent data do not show a connection between a popular inhaler and previously reported risks of stroke, heart attack and death. The Spiriva HandiHaler... ... (Read whole news on source site)
-
2010-01-15 10:01:00
Notes From J.P. Morgan: Daschle Disses DTC - FDA Clears Spiriva HandiHaler Of Increased Cardiovascular Risk - Nothing Anemic About Ferahame: The Med Helps Amag Exceeds Street Expectations - Pharma Companies Respond To Haiti Crisis With Medicine And Cash Donations
-
2010-01-15 03:51:00
The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva, Tiotropium HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the m ...
-
2010-01-14 23:48:00
HealthDay - THURSDAY, Jan. 14 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday said it found no good evidence that the Spiriva HandiHaler boosts heart risks in patients who use it to help control chronic obstructive pulmonary disease (COPD).
|